DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain Tumors

NCT00978562 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Childhood Brain Neoplasm
Recurrent Childhood Brain Neoplasm

Interventions

PROCEDURE: Dynamic Contrast-Enhanced Magnetic Resonance Imaging
PROCEDURE: Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
DRUG: Ferumoxytol Non-Stoichiometric Magnetite
DRUG: Gadolinium

Sponsor

OHSU Knight Cancer Institute

Collaborators

[object Object]